51 – 60 of 323
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells
- Contribution to journal › Article
- 2021
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
- Contribution to journal › Scientific review
-
Mark
Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease
- Contribution to journal › Article
-
Mark
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease : A Structured Review
- Contribution to journal › Scientific review
-
Mark
TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
- Contribution to journal › Article
-
Mark
Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons
- Contribution to journal › Article
-
Mark
Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
- Contribution to journal › Article
